ATI RN
ATI Mental Health Practice A
1. Which of the following medications is commonly used to treat attention-deficit/hyperactivity disorder (ADHD)?
- A. Haloperidol
- B. Fluoxetine
- C. Methylphenidate
- D. Clozapine
Correct answer: C
Rationale: Methylphenidate is a central nervous system stimulant commonly used in the treatment of ADHD. It helps improve focus, attention, and impulse control in individuals with ADHD. Haloperidol and clozapine are antipsychotic medications typically used for other conditions such as schizophrenia, while fluoxetine is a selective serotonin reuptake inhibitor commonly used to treat depression and anxiety disorders. Therefore, the correct answer is Methylphenidate (Choice C).
2. When assessing a client diagnosed with major depressive disorder who states, 'I feel like I can't go on,' which of the following actions should the nurse take first?
- A. Administer a prescribed antidepressant medication.
- B. Ask the client if they have a plan to commit suicide.
- C. Encourage the client to attend a support group.
- D. Contact the client's family to provide support.
Correct answer: B
Rationale: The priority action for the nurse is to assess the client's risk for suicide. By asking if the client has a plan to commit suicide, the nurse can determine the immediate safety of the client and take appropriate interventions to prevent harm. Administering antidepressant medication is not the first action to take in this situation as assessing the client's safety is the priority. Encouraging the client to attend a support group or contacting the client's family, although beneficial, are not immediate actions to ensure the client's safety in a crisis situation.
3. Which client statement indicates an understanding of the education provided about the antidepressant medication sertraline (Zoloft)?
- A. I should take this medication on an empty stomach.
- B. It may take several weeks for this medication to be effective.
- C. I can stop taking this medication when I feel better.
- D. I should avoid taking this medication with other medications.
Correct answer: B
Rationale: Choice B is the correct answer. It is crucial for clients to understand that sertraline (Zoloft) may take several weeks to show its full effects. Patients should be informed about this delay in onset of action to set realistic expectations and adhere to the treatment plan. This education helps prevent premature discontinuation of the medication due to perceived lack of efficacy. Choices A, C, and D are incorrect. Choice A is inaccurate because sertraline (Zoloft) should be taken with food to reduce the risk of gastrointestinal side effects. Choice C is incorrect because abruptly stopping the medication can lead to withdrawal symptoms and worsening of the condition. Choice D is inaccurate as there are specific medications that should be avoided with sertraline, but a general statement to avoid all other medications is overly broad and not necessary.
4. A patient with obsessive-compulsive disorder (OCD) is undergoing treatment with an SSRI. Which SSRI is commonly utilized for this condition?
- A. Fluoxetine
- B. Citalopram
- C. Paroxetine
- D. Escitalopram
Correct answer: C
Rationale: Paroxetine is a selective serotonin reuptake inhibitor (SSRI) commonly prescribed for obsessive-compulsive disorder due to its efficacy in managing OCD symptoms. While different SSRIs may be used based on individual patient response and tolerability, Paroxetine stands out as a well-established option for treating OCD. Fluoxetine (Choice A) is another SSRI commonly used for OCD, but Paroxetine is more commonly associated with this indication. Citalopram (Choice B) and Escitalopram (Choice D) are also SSRIs but are not typically the first choice for treating OCD.
5. Which approach involves surgically implanting electrodes into specific areas of the brain to stimulate regions identified as underactive in depression?
- A. Transcranial magnetic stimulation
- B. Deep brain stimulation
- C. Vagus nerve stimulation
- D. Electroconvulsive therapy
Correct answer: B
Rationale: Deep brain stimulation is a treatment approach that involves the surgical implantation of electrodes into specific areas of the brain to stimulate regions identified as underactive in depression. This method aims to modulate brain activity and has shown effectiveness in treating certain cases of depression.
Similar Questions
Access More Features
ATI RN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI RN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access